European Journal of Medicinal Chemistry · 2014 · 35 citations · 41 references
PharmacyChemistryMedicinal ChemistryCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryEnzyme InhibitionPharmacodynamics Of Anticancer AgentsTyrosine Kinase InhibitorsAnticancer ActivityAnticancer ChemotherapyMedicinal HeterocyclesQuinoline AlkaloidsQuinoline ChemistryQuinoline Synthesis
41
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn, Carla Milagre, Steven R. Whittaker et al. · Cell · 2010 · 1.5K citations · Full text
Regulation and Role of Raf-1/B-Raf Heterodimerization
Linda Rushworth, Alison D. Hindley, Eric O’Neill et al. · Molecular and Cellular Biology · 2006 · 417 citations · Full text
Siu Tsan Yuen, Helen Davies, Tsun Leung Chan et al. · PubMed · 2002 · 411 citations
Active Ras induces heterodimerization of cRaf and BRaf.
C. Weber, Joseph R. Slupsky, H A Kalmes et al. · PubMed · 2001 · 320 citations